Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Royal Bank of Canada (RY) Price & Performance

Royal Bank of CanadaTrade

Price performance (Past 24H)

Key statistics

Alcon AG vs Royal Bank of Canada — how do they compare? Alcon AG trades at $72.66 (market cap $36.44B), while Royal Bank of Canada trades at $212.3 (market cap $292.32B). The key difference: Royal Bank of Canada is far larger — about 8× Alcon AG's market cap, and Royal Bank of Canada pays the higher dividend (2.37%). Which is the better fit depends on your goals.

ALCRY
Market Cap
$36.44B$292.32B
Sector
HealthFinancials
52-Week High
$90.12$217.87
52-Week Low
$62.02$134.80
Enterprise Value
$40.28B
Dividend Yield
0.48%2.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alcon AG

ALC trades at $73.63, up 2.53% today, with a bullish technical signal from moving averages and strong recent earnings beats. Revenue growth is steady, reaching $10.40B in 2025, though net income margin dipped to 5.92%. Positive news includes raised 2026 profit guidance and new product launches driving investor optimism.

The outlook is positive with a consensus price target of $86.67 implying 17.7% upside, supported by analyst buy ratings. Risks include elevated P/E of 57.52 and potential tariff impacts, but operational cash flow strength and strategic collaborations provide a solid foundation for growth.

Royal Bank of Canada

Royal Bank of Canada (RY) trades at $210.79, down slightly by 0.14% today. The stock shows a bullish technical trend with strong earnings performance, beating EPS estimates in three consecutive quarters. Revenue grew to $66.53 billion in 2025, with a net income margin of 31.85%. Analyst sentiment is mixed with a Buy consensus of 43% but a majority Hold rating. Recent insider selling and a dividend announcement highlight corporate activity.

RY presents a stable investment with solid profitability and dividend yield, but faces risks from high valuation multiples and macroeconomic sensitivity. Upside is supported by earnings growth and institutional holdings, while insider sales and debt levels warrant caution. The stock remains a core holding for dividend-focused portfolios amid moderate growth expectations.

Returns comparison

Trailing returns across standard periods

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Royal Bank of Canada

Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.

Read more on RY